HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru [NA]
The trial assesses the acceptability, feasibility, and preliminary impact of a web-based HIV prevention toolkit among cisgender male couples…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Testing of the JomPrEP App for HIV Prevention Among Malaysian MSM [NA]
The trial evaluating the JomPrEP app for HIV prevention among Malaysian men who have sex with men has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Testing of the Smartphone App to Enhance HIV Prevention Cascade Among Malaysian MSM [NA]
A clinical trial evaluating a smartphone app to enhance HIV prevention among Malaysian men who have sex with men has completed. The study is…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: HIV Testing in Community Health Center Dental Clinics [NA]
This clinical trial aims to study HIV testing in dental clinics affiliated with community health centers and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study [Phase 1]
Phase 1 study evaluating a rectal insert containing tenofovir alafenamide and elvitegravir for HIV prevention has completed, with safety iss…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Onboarding Positives and PrEP Users to Engage Negatives (OPPEN): Peer-driven Education to Link YMSM of Color to PrEP [NA]
The University of California, San Diego completed the OPPEN study, a peer-driven education program intended to connect young men who have se…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2) [Phase 1]
A Phase 1 trial of MK-6186 (MK6186-007 AM2) in HIV-1 infected patients was terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Start the Conversation: Evaluating Implementation of a Multi-level PrEP Initiative for Black Cisgender Women in Nola [NA]
A Duke University trial evaluating a multi-level PrEP implementation for Black cisgender women in New Orleans has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B [Phase 3]
A Phase 3 trial (BEe-HIVe) evaluated HEPLISAV-B for hepatitis B vaccination in persons living with HIV. The study has completed and results …
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM [Phase 3]
Phase 3 trial results report on switching virologically suppressed HIV-1-infected patients from Lamivudine 150 mg BID plus Raltegravir 400 m…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load [Phase 4]
A Phase 4 trial assessed the efficacy and safety of a rilpivirine-based antiretroviral regimen in HIV-infected patients with non-alcoholic f…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine [Phase 4]
Phase 4 trial assessing the virological and immunological safety of a dose-reduction strategy for an efavirenz/tenofovir/emtricitabine antir…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: [Phase 4]
Phase 4 trial comparing dolutegravir/lamivudine (DTG/3TC) versus bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as maintenanc…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities [Phase 4]
Phase IV trial assessing safety and convenience of switching virologically controlled people with HIV from dolutegravir/lamivudine to bicteg…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV [Phase 2]
A Phase 2 trial evaluated the safety and immunogenicity of the tuberculosis vaccine M72/AS01E in people with well-controlled HIV, with resul…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV [Phase 2]
Phase 2 trial evaluating cenicriviroc mesylate for reducing arterial inflammation in people living with HIV has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Can INSTI-associated Weight Gain be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF? [Phase 4]
A Phase 4 trial investigated whether switching to the fixed-dose combination doravirine/lamivudine/tenofovir disoproxil fumarate could halt …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: The Blued+ Combination HIV Prevention Pilot Study in China
The Blued+ combination HIV prevention pilot trial in China has completed, with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels [Phase 4]
Phase 4 trial comparing rosuvastatin to switching protease inhibitors in people with HIV and high cholesterol; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection [Phase 2]
Phase 2 study evaluating teropavimab and zinlirvimab in combination with lenacapavir for virologically suppressed adults with HIV-1 infectio…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine [Phase 4]
This Phase 4 clinical trial update reports on the out-of-hospital administration of the long-acting cabotegravir plus rilpivirine regimen fo…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Using Smart Phone Technology to Support HIV Medication Refill Adherence in Virginia [NA]
A completed clinical trial from the University of Virginia evaluated using smartphone technology to support adherence to HIV medication refi…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test [NA]
This document reports on a completed clinical trial evaluating the performance, usability, and result interpretation of the INSTI HIV Self-T…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Evaluating HITSystem 2.1 to Improve Viral Suppression in Kenya [NA]
Completed clinical trial results evaluating HITSystem 2.1 in Kenya aimed at improving viral suppression among people with HIV, including pre…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Partner Services Pre-exposure Prophylaxis (PS-PrEP) [NA]
The PS-PrEP clinical trial update indicates the Partner Services Pre-exposure Prophylaxis study sponsored by the University of Chicago has c…